These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 795109)

  • 1. A genetic survey of rat cardiac allograft rejection in presensitized recipients.
    Guttmann RD
    Transplantation; 1976 Dec; 22(6):583-8. PubMed ID: 795109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro correlates of rejection. II. Rat mixed lymphocyte reactivity in vitro and cardiac allograft acute rejection, hyperacute or accelerated rejection, and prolongation by active immunization.
    Guttmann RD
    Transplantation; 1977 Feb; 23(2):153-7. PubMed ID: 138229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine abrogation of second-set rejection: dependence upon major histocompatibility complex disparity.
    Schulak JA; Engelstad K
    J Surg Res; 1985 Apr; 38(4):400-6. PubMed ID: 3158782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro correlates of rejection. I. Suppressive effect and specificity in mixed lymphocyte interaction of alloantiserum producing hyperacute rejection.
    Guttmann RD
    Transplant Proc; 1977 Mar; 9(1):755-60. PubMed ID: 68601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
    Makowka L; Chapman FA; Cramer DV; Qian SG; Sun H; Starzl TE
    Transplantation; 1990 Sep; 50(3):359-65. PubMed ID: 2402783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the haplotypes of the major histocompatibility complex in the rat. III. Two difficult haplotypes: H-1h (Ag-B12) in the HW strain and Ag-B13 (H-1m) in the MNR/N strain.
    Stark O; Kunz HW; Gill TJ
    J Immunogenet; 1978 Aug; 5(4):261-73. PubMed ID: 366023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal versus systemic venous drainage for small-bowel allografts.
    Schraut WH; Abraham VS; Lee KK
    Surgery; 1985 Sep; 98(3):579-86. PubMed ID: 3875908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
    J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of acute rejection of rat cardiac allografts and a model of hyperacute rejection.
    Guttmann RD
    Transplantation; 1974 Apr; 17(4):383-6. PubMed ID: 4595923
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac allograft rejection and enhancement in natural recombinant rat strains.
    Guttmann RD; Forbes RD; Cramer DV; Gill TJ
    Transplantation; 1980 Sep; 30(3):216-8. PubMed ID: 14582179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Yunnan-cobra venom factor in overcoming acute humoral rejection after allograft cardiac transplantation in presensitized recipients: experiment with rats].
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1460-3. PubMed ID: 16842697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts.
    Wu S; Xu H; Chen B; Wen Y; Ikusika OM; Ocker A; Zhao H; Ildstad ST
    Transplantation; 2011 Sep; 92(6):627-33. PubMed ID: 21822173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance or rejection: A delicate balance as judged by exposure of heart-transplanted rats to the immunomodulator Linomide.
    Qi Z; Tufveson G; Ekberg H
    Scand J Immunol; 1999 Oct; 50(4):394-8. PubMed ID: 10520179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies in diabetic rat recipients with a pancreatic islet cell allograft in the brain.
    Tze WJ; Tai J
    Transplantation; 1989 Jun; 47(6):1053-7. PubMed ID: 2499961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant study.
    Hosenpud JD; Boyle TM; Hensler H; Sanford G; Khanna AK
    Transplantation; 2000 May; 69(10):2173-8. PubMed ID: 10852619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.